Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marchex (MCHX) Asset Writedowns and Impairment (2020 - 2025)

Marchex (MCHX) has disclosed Asset Writedowns and Impairment for 4 consecutive years, with $123000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 301.64% to $123000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $59000.0, a 80.13% decrease, with the full-year FY2024 number at -$147000.0, down 122.93% from a year prior.
  • Asset Writedowns and Impairment was $123000.0 for Q3 2025 at Marchex, up from $7000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $432000.0 in Q4 2023 to a low of -$99000.0 in Q2 2024.
  • A 3-year average of $51363.6 and a median of $25000.0 in 2024 define the central range for Asset Writedowns and Impairment.
  • Biggest YoY gain for Asset Writedowns and Impairment was 301.64% in 2025; the steepest drop was 336.0% in 2025.
  • Marchex's Asset Writedowns and Impairment stood at $432000.0 in 2023, then plummeted by 102.78% to -$12000.0 in 2024, then skyrocketed by 1125.0% to $123000.0 in 2025.
  • Per Business Quant, the three most recent readings for MCHX's Asset Writedowns and Impairment are $123000.0 (Q3 2025), $7000.0 (Q2 2025), and -$59000.0 (Q1 2025).